N Stefan, K Kantartzis, HU Haring - Endocrine Reviews, 2008 - Endocrine Soc Type 2 diabetes and cardiovascular disease represent a serious threat to the
health of the population worldwide. Although overall adiposity and particularly
visceral adiposity are established risk factors for these diseases, in the ... Cited by 15 - Related articles - All 4 versions
- ►nursing2008.com C Weikert, N Stefan, MB Schulze, T Pischon, … - Circulation, 2008 - Am Heart Assoc From the Departments of Epidemiology (CW, MBS, TP, HB) and Pharmacology (HJ),
German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany;
Institute for Social Medicine, Epidemiology, and Health Economics, Charité ... Cited by 5 - Related articles - All 9 versions
- ►endojournals.org T Reinehr, CL Roth - Journal of Clinical Endocrinology & Metabolism, 2008 - Endocrine Soc Context: There are very limited data available concerning the relationships
between fetuin-A, weight status, nonalcoholic fatty liver disease (NAFLD), and
features of the metabolic syndrome (MetS) in obese humans, and especially ... Cited by 4 - Related articles - All 4 versions
M Roos, T Richart, T Kouznetsova, M von … - Regulatory Peptides, 2009 - Elsevier Fetuin-A levels were negatively correlated with aPWV (r = − 0.21, p = 0.029).
After an adjustment for multiple covariables, fetuin-A levels were independently
associated with aPWV (r = − 0.30, p = 0.022) in males but not in females. ... Cited by 2 - Related articles - All 2 versions
RB Goldberg - Journal of Clinical Endocrinology & Metabolism, 2009 - Endocrine Soc Evidence: Circulating biomarkers of these pathways such as TNF , IL-6,
C-reactive protein (CRP) (inflammation), vascular cellular adhesion molecule-1,
interstitial cellular adhesion molecule-1, E-selectin, von Willebrand ... Cited by 2 - Related articles - All 3 versions
JH Ix, CL Wassel, GM Chertow, A Koster, KC … - Journal of Clinical Endocrinology & Metabolism, 2009 - Endocrine Soc Joachim H. Ix, Christina L. Wassel, Glenn M. Chertow, Annemarie Koster, Karen C.
Johnson, Frances A. Tylavsky, Jane A. Cauley, Steven R. Cummings, Tamara B.
Harris, and Michael G. Shlipak, for the Health Aging and Body Composition ... Related articles - All 2 versions
SV Kaushik, EP Plaisance, T Kim, EY Huang, … - Diabetes/Metabolism Research and Reviews, 2009 - interscience.wiley.com Fetuin-A, a liver-secreted phosphoprotein and physiological inhibitor of insulin
receptor tyrosine kinase, is associated with insulin resistance, metabolic
syndrome (MetS), and an increased risk for type 2 diabetes. However, ... Related articles - All 2 versions
- ►tcgroup.it [PDF] NF Schwenzer, F Springer, C Schraml, N … - Journal of Hepatology, 2009 - Elsevier Hepatic steatosis is the most prevalent liver disorder in the developed world.
It is closely associated with features of metabolic syndrome, especially insulin
resistance and obesity. The two most common conditions associated with ... Related articles - All 19 versions
C Weikert, N Stefan, MB Schulze, T Pischon, K … - Circulation, 2008 - pt.wkhealth.com From the Departments of Epidemiology (CW, MBS, TP, HB) and Pharmacology (HJ),
German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany;
Institute for Social Medicine, Epidemiology, and Health Economics, Charité ...
T Pischon - Disease Markers, 2009 - IOS Press Abstract. Obesity is an established risk factor for cardiovascular disease
(CVD), yet, the underlying mechanisms are only poorly understood. The adipose
tissue produces a variety of hormones and cytokines and thereby actively ... Related articles - All 2 versions
